rAAV2tYF-GRK1-RPGR

RPGR gene therapy vector using AAV2 capsid with tYF-GRK1 modifications · Beacon Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV2tYF-GRK1-RPGR, covering 2024-05-20 to 2024-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations [Phase 1, Phase 2]

See pricing